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Abstract
Quantification of 241Am in urine at low levels is important for assessment of individuals’ or 
populations’ accidental, environmental, or terrorism-related internal contamination, but no 
convenient, precise method has been established to rapidly determine these low levels. Here we 
report a new analytical method to measure 241Am as developed and validated at the Centers for 
Disease Control and Prevention (CDC) by means of the selective retention of Am from urine 
directly on DGA resin, followed by SF-ICP-MS detection. The method provides rapid results with 
a Limit of Detection (LOD) of 0.22 pg/L (0.028 Bq/L), which is lower than 1/3 of the C/P CDG 
for 241Am at 5 days post-exposure. The results obtained by this method closely agree with CDC 
values as measured by Liquid Scintillation Counting, and with National Institute of Standards 
Technology (NIST) Certified Reference Materials (CRM) target values.
 Introduction
Americium is a man-made, radioactive, metallic element produced when plutonium atoms 
undergo successive neutron capture events in nuclear reactors, in nuclear weapons, and 
during nuclear weapons’ detonations. Americium has several different isotopes, all of which 
are radioactive. The most important and prevalent americium isotope is 241Am, with a half-
life of 432.7 years. As it decays, 241Am releases alpha particles at 5.44 MeV (13%) and 5.49 
MeV (84.5%), becoming 237Np, which (in 35.9% of the decays) immediately emits gamma 
radiation at 59.5 keV. The 241Am decay chain ends with 209Bi, a nonradioactive 
element. 241Am in the environment originated from atmospheric testing of nuclear weapons 
during the 1950s and 1960s, as well as reprocessing plants and nuclear accidents. Facilities 
that are involved with nuclear weapons, well logging sources and manufacture smoke 
detectors are minor sources of 241Am contamination [1].
The critical 241Am exposure pathways are inhalation and ingestion. 241Am poses significant 
health hazards, even in small concentrations, if it is taken into the body in a soluble form. 
Once in the body, 241Am concentrates in the skeleton, liver, and muscle. It can stay in the 
body for decades and continue to expose the surrounding tissues to both alpha and gamma 
radiation. Long-term internal exposure to 241Am may create an increased risk of developing 
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cancer. Exposure to any significant amount of 241Am is unlikely under normal 
circumstances [1, 2].
Several techniques exist for the determination of 241Am concentration in environmental and 
human samples [3, 4]. Gamma spectrometry, using High Purity Germanium detectors, is the 
primary tool used to determine 241Am at levels of 0.1−1 Bq/kg or higher; but to obtain 
accurate results, it requires that the user correct for the attenuation of gamma rays in the 
samples [5, 6]. Alpha spectrometry is the most commonly applied technique for 
determination of low-level 241Am content. Its principal advantages are relatively low 
equipment costs, high sensitivity due to low background, and high selectivity for alpha 
particles against other types of radiation [3]. A limit of detection (LOD) of 10−20 mBq/kg 
has been reported for various sample matrices, depending on the counting time and count 
rate of the procedure blank [7–9]. However, tedious, time-consuming sample preparation 
procedures (e.g., precipitation, evaporation, elution, filtration, electroplating, etc.) and long 
measurement times limit throughput. Such preparation procedures are due to possible 
interference from other radionuclides with close alpha energies, and long counting times are 
necessary because of 241Am’s relatively low specific activity.
SF-ICP-MS offers substantial advantages over conventional radiometric techniques and has 
recently been used for analysis of many long-lived radionuclides in various sample matrices. 
It is one of the fastest methods for 241Am analysis [10–13]. An LOD of 1 pg/L for 241Am 
has been reported on SF-ICP-MS [14]. This LOD is comparable to that of alpha 
spectrometry, assuming no interferences exist for SF-ICP-MS. However, the main analytical 
issue in SF-ICP-MS originates from isobaric and polyatomic interferences such 
as 241Pu+, 240PuH+, 209Bi32S+, 209BiO2+, 206Pb35Cl+, 204Pb37Cl+, 205Tl36Ar+, 207Pb34S+, 
and 201Hg40Ar+ [11]. The major isobaric interference with 241Am is 241Pu. Since 241Am is 
the decay product of 241Pu (half-life is 14.33 years), in some samples of reactor origin the 
concentration of 241Am is comparable to that of 241Pu. Therefore, the method includes a 
thorough chemical separation of 241Pu (which also removes most of the other interfering 
molecular ions) from the samples [11, 15].
Developing methods to determine exposure to 241Am is within CDC’s public health mission. 
Quantitative analysis of 241Am in urine is considered a useful, noninvasive way to assess 
levels of internal contamination. Our Emergency Response Analytical goal is to be able to 
detect threat-radionuclides in urine at levels well below (i.e., 1/3 of or lower) the levels for a 
general population or for special subgroups such as children or pregnant woman (C/P) at the 
National Council on Radiation Protection & Measurements (NCRP) Report No. 161 Clinical 
Decision Guide (CDG) based action level of 0.73 pg/L (0.093 Bq/L) for 241Am (urine output 
expected at 5 days post intake) [16]. CDC’s IRATB recently developed a urine Gross Alpha/
Gross Beta method using Liquid Scintillation Counting (LSC) [17]. However, the LOD of 
this method for 241Am is 4.2 Bq/L, equivalent to 32.3 pg/L, which is much higher than the 
C/P CDG of 0.73 pg/L for 241Am.
In this study, we report a novel and rapid analytical method for determination of 241Am in 
urine samples. The Solid Phase Extraction (SPE) part of the method is based on preliminary 
studies carried out by Horwitz, et al. [18], Li, et al. [19] and Sadi, et al. [20] using a single 
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DGA resin cartridge to separate Am from other actinides such as U and Pu. We further 
optimized the method to isolate 241Am from a 10-mL volume of urine using simple 
extraction steps and used SF-ICP-MS for detection instead of LSC. The study’s purpose was 
to develop a rapid, simple method to address and respond to public health or other 
accidental, environmental, or terrorism-related exposures to 241Am. This method is not 
designed to characterize the normal background level of 241Am in the non-occupationally 
exposed population, but it does have a detection limit below the suggested CDG action 
levels. Thus it can serve as a means of rapidly identifying both adults and children who have 
been exposed to 241Am and who might require medical intervention.
 Experimental
 Reagents and solutions
DGA Cartridges (normal, 1 mL) and a polycarbonate vacuum box (24 holes) were purchased 
from Eichrom Technologies (Darien, IL, USA). All nitric (HNO3) and hydrochloric (HCl) 
acid solutions were prepared from double-distilled (DD) acids (GFS Chemicals Inc. 
Columbus, OH). Deionized water was used for all solutions (≥ 18 MΩ·cm, from an Aqua 
Solutions Ultrapure Water System, Aqua Solutions, Inc., Jasper, GA). “Base urine” was 
collected through anonymous human donations (CDC protocol 3994) and acidified to 1% 
v/v HNO3. All radioactivity solution sources were traceable to the National Institute for 
Standards and Technology (NIST, Gaithersburg, MD, USA). Both low and high quality 
control (QC) solutions and other urine pools for LOD were prepared for determination by 
spiking base urine with dilutions of an 241Am isotope standard (Eckert & Ziegler Analytics, 
Inc., Atlanta, GA). A series of aqueous 241Am Certified Reference Materials (CRM) 
solutions were prepared by dilution of 241Am radioactive source solutions from 
NIST. 243Am (Eckert & Ziegler Analytics Inc., Atlanta, GA) was used as an internal 
standard (tracer). Sodium nitrite (Sigma-Aldrich, St. Louis, MO) was used to adjust the 
oxidation states. Serial dilutions of uranium, lead, thallium, mercury, bismuth single-element 
stock standards (SPEX Industries, Inc., Edison, NJ) and a 242Pu radioactivity solution (U.S. 
Department of Energy, New Brunswick Laboratory, Argonne, IL) were spiked into the urine 
samples to verify that high separation factors for U, Pb, Tl, Hg, Bi and Pu were obtained 
using this SPE procedure.
 Sample preparation
The urine sample volume for a single analysis is 10 mL. Allow urine specimens to reach 
ambient temperature, shake or vortex them to mix for 5 seconds before pipetting. Spike 400 
µL of 1 ng/L 243Am solution as an internal standard (tracer) to every 10 mL of urine patient 
sample or QC sample. Add 4.76 mL of concentrated HNO3 (68–70%, the final concentration 
in the sample is 5M) and then 0.13g of sodium nitrite to each sample as a valence adjuster to 
convert Pu to the tetravalent state. Shake or vortex to mix the samples for 5 seconds and let 
reaction occur at room temperature for at least 10 minutes. Load each sample on a DGA 
resin cartridge of 1 mL bed volume (cartridge preconditioned with 15 mL of 5 M HNO3 
using a vacuum box). Rinse the cartridge again with 15 mL of 5M HNO3 followed by 15 mL 
× 3 of 0.5M HNO3 using a vacuum box. Strip 241Am from the column with 5 mL of 0.5M 
HCl. Transfer 1 mL of the purified samples into 4 mL polystyrene conical bottom sample 
Xiao et al. Page 3
J Radioanal Nucl Chem. Author manuscript; available in PMC 2016 July 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
cups for analysis (Figure 1). Prepare external, aqueous-based stock calibration standards by 
spiking 0.5M HCl with dilutions of 241Am isotope standard, and then add 40 µL of internal 
standard solution (1 ng/L 243Am) to every 1 mL of standards to reach the same tracer 
concentration as the patient and QC samples. Prepare both calibration standards and sample 
blanks as 0.5 M HCl solutions, which match the elute solutions for the column of this 
method.
 Instrumentation
This method measures 241Am concentrations using an extended dynamic range, high-
resolution ICP-MS model Element XR (Thermo Fisher Scientific, Bremen, Germany), 
which is a double-focusing, magnetic sector, inductively-coupled-plasma mass spectrometer 
with a single discrete dynode detector (Mascom, Bremen, Germany). It uses the ICP-MS, 
equipped with nickel sampler and skimmer cones and a CD-2 guard electrode, in triple 
mode. The sample introduction system consists of a computer-controlled ASX-112 (Cetac, 
Omaha, NE) autosampler and an Aridus II™ (Cetac, Omaha, NE) desolvation unit. As 
discussed in our lab’s previous report [21], the Aridus II™ setup increases the sensitivity of 
the SF-ICP-MS by more than 10 times, enabling the measurement of 241Am at the low level 
of < 1 pg/L. Samples self-aspirate from the autosampler into the desolvation unit through an 
Apex perfluoroalkoxy (PFA) 100 μL/minute nebulizer (ESI, Omaha, NE, or equivalent). The 
desolvation unit, equipped with an upgraded PFA spray chamber, operates at 110 °C. With 
the aid of argon sweep gas and nitrogen gas for sensitivity enhancement, the sample passes 
through a semi-permeable membrane coil in the unit that operates at 160°C. Optimize flow 
rates as needed, with argon sweep gas at ~ 3−7 L/min and nitrogen gas at ~ 3−7 mL/min. 
The desolvated sample exits the unit into a 1.8 mm I.D. sapphire injector and a standard 
quartz torch, and then into the mass spectrometer. All experimental parameters are optimized 
for 241Am concentrations determination by SF-ICP-MS with respect to maximum ion 
intensity of 238U and minimum uranium oxide formation rate using a 5 ng/L natural uranium 
tuning solution. Table 1 contains a summary of our optimized operating conditions.
 Results and discussion
 Removal of potential spectral interferences
Potential interferences for analysis of 241Am include isobaric overlaps with 
anthropogenic 241Pu and polyatomic overlaps 
with 240PuH+, 209Bi32S+, 209BiO2+, 206Pb35Cl+, 204Pb37Cl+, 205Tl36Ar+, 207Pb34S+, 
and 201Hg40Ar+. To test for complete removal of 241Pu, a 50 pg/L solution of 242Pu isotope 
spike in base urine was prepared and tested. Experiments showed more than 99% of 242Pu is 
removed by the SPE portion of sample preparation. Using SPE sample preparation as 
described above, Pb, Tl, and Hg, spiked in base urine at concentrations of 3 µg/L, 0.5 µg/L, 
and 5 µg/L respectively, did not result in apparent (> 0.1 pg/L) 241Am concentrations. These 
spiked urine samples’ concentrations were above the National Health and Nutrition 
Examination Survey (NHANES) 95th percentile of urine Pb, Tl, and Hg concentrations [22]. 
Although no NHANES survey data was available for bismuth, analysis of what was 
otherwise determined [23, 24] to be a high urine concentration (5 µg/L) of Bi, produced no 
apparent 241Am concentration.
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Performance of a natural U-spike experiment determined that due to peak tailing, small 
interferences remained at m/z = 241 when the separated sample solutions contain high levels 
of U (> 0.5 µg/L). Analysis of urine samples with U =1.0 µg/L with this SPE method as part 
of the sample preparation procedure removed more than 99% of the U that might cause 
tailing into the m/z=241 region. Samples having U concentrations higher than 10.0 µg/L (the 
NHANES 95th percentile of U concentration in urine of normal U. S. residents is 0.031 
µg/L) [22] should be treated by the modified sample preparation procedure as shown in 
Figure 1, which will be described in more detail below.
 Limit of detection
The LOD for 241Am in urine specimens is based on 60 analytical runs of 4 different low-
concentration samples close to the LOD (a first approximation of LOD is the measured 
blank concentration plus 3 times the Standard Deviation (SD) of the measured blank 
concentration) and was calculated according to the formula:
ConcLOD= [meanb + 1.645(Sb + int)]/[1-1.645(slope)], where mean b = blank 
average, Sb = standard deviation of blank average, int = intercept of the equation of 
SD versus concentration for LOD samples analyzed at least 60 times, Slope = slope 
of the equation of SD versus concentration for LOD samples analyzed at least 60 
times.
The LOD of this method is 0.22 pg/L (Figure 2). This LOD is < 1/3 of the C/P CDG (~0.734 
pg/L), and is therefore acceptable for an emergency radiobioassay method for determining 
the concentration of 241Am in urine collected at 5 days post-exposure.
 Linearity
A linearity study determined the linear reportable range for this method. The method 
exhibits good linear signal response between concentrations of 0.3 pg/L and 1000 pg/L 
of 241Am with a Coefficient of Determination of 1.000. The normal calibration range is from 
0.3 pg/L to 30 pg/L, and the extended calibration range is from 30 pg/L to 1000 pg/L. If a 
urine 241Am value is above the highest calibrator, the urine sample is diluted with 5% HNO3 
to bring the concentration within the validated calibration range.
 Internal methods comparison study
A comparison of urine sample analysis results was performed between this method and our 
CLIA validated LSC method. The two samples LU-077203 and HU-077201 were prepared 
as QC material and, using LSC, analyzed for 241Am at relatively high concentrations. They 
then were diluted 1:1000 to get within the desired 241Am concentration range for the present 
method, purified and analyzed using SF-ICP-MS. The difference between the described 
methods is 2.1% to 3.0% (Table 2),
 Precision and accuracy
Analysis of serial aqueous dilutions of a Certified Reference Material (CRM) from NIST 
was also used to verify method accuracy. The observed 241Am concentrations were in close 
agreement with the target values, with an analytical bias from −0.3% to 1.7% (Table 2). 
Table 2 also shows the typical precision observed at different concentrations of daily quality 
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control materials analyzed at the beginning, in the middle, and at the end of each analytical 
run. Accuracy and precision of the reported results was assured based on adherence to the 
quality control/quality assurance program of the Division of Laboratory Sciences, NCEH, 
CDC [25].
 Analysis of samples from the NIST Radiochemistry Intercomparison Program (NRIP)
NRIP is a performance evaluation program which provides high quality, traceable 
radionuclide materials to support low-level radioanalytical laboratories conducting 
environmental and radiobioassay radioactivity measurements. 241Am is among the 
radionuclides used for testing. However, we found that the extraordinarily high 
concentrations of uranium present in these samples (intended for evaluation of 
environmental levels of uranium by alpha spectrometry) significantly affects the accuracy of 
trace level 241Am determination by SF-ICP-MS. Further, these uranium concentrations 
would possibly produce significant, troublesome instrument contamination. To address this 
problem we developed and recommend a modified sample preparation procedure that is 
further optimized for samples with extremely high U content (usually higher than 10 µg/L).
In this procedure, after rinsing the cartridge with 15 mL of 5M HNO3 followed by 15 mL × 
3 of 0.5M HNO3, replace both the cartridge reservoirs and tips to eliminate possible U 
deposits and rinse the cartridges with more 0.5M HNO3 (15 mL × (3 - 6) of 0.5M HNO3, 
see Figure 1). Table 3 and Table 4 show the results observed for 241Am analysis of the NRIP 
samples. These samples were from two radiobioassay preparedness exercises during 2012 
with different turnaround times (TATs): one 60 days, and one 8 hours. These synthetic urine 
samples typically have U concentrations ranging from 140 µg/L to 450 µg/L. After the more 
aggressive rinsing procedure, U concentrations in the elution solutions were under 0.20 
µg/L, and did not result in apparent 241Am signal contribution for these samples. All but one 
result had slight negative bias (average −2.1 +/− 2.4% at a 95% Confidence Level) compared 
with the NIST target values. Most of the observed results for the NRIP samples show a small 
negative bias compared to the NIST target values, indicating a slight negative systematic 
uncertainty. One result had a positive bias of 12.7%. We noted that analyses of this sample 
for other radionuclides yielded a similar positive bias, indicating an external sample 
preparation error, as opposed to method bias.
 Sample turnaround time (TAT)
While maintaining high quality results, sample TAT is one of the important considerations in 
a radiological emergency. For this method, ~ 2.5 hours are required to pretreat the urine 
samples for a batch of 20 patient urine specimens plus QC samples. An additional 3.5 hours 
are required for final analysis of 20 patient samples by SF-ICP-MS, including calibrators, 
blanks, and QC samples. Samples may be pretreated concurrently with final SF-ICP-MS 
analysis, resulting in a daily throughput of approximately 120 samples per day (24 hours) 
per instrument.
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 Conclusions
We introduced a method for rapidly determining ultra-low levels of 241Am in urine samples 
using a Solid Phase Extraction purification procedure and a high-sensitivity sample 
introduction system (Aridus II™), coupled with SF-ICP-MS. This method provides for 
analysis of 241Am at very low levels, with a LOD of 0.22 pg/L (well below the C/P CDG 
level) and allows rapid throughput of samples. It attained good agreement, with a bias of 
2.1%−3.0%, for urine samples in an internal comparison with a CDC LSC method. It also 
produced recoveries from 99.7% to 101.7% in analysis of aqueous dilutions of 241Am SRM 
from NIST.
This method’s efficient urine sample separation scheme effectively eliminates most 
molecular ion interferences. However, if urine samples contain more than 10 µg/L of U, 
more aggressive rinsing procedures are required to eliminate U from the elution solutions. 
The results obtained by this method for NIST/NRIP reference materials with high-U levels 
are in close agreement with the NIST target values, with biases ranging from −0.62% to 
−5.61%.
A major advantage of this method over alpha spectrometry and other methods is that only a 
small, 10 mL volume of each urine sample is needed to perform the analysis, making 
successful analysis more likely, especially for young children and infants.
This procedure is appropriate for rapid identification and quantification of 241Am in urine 
for emergency response involving accidental or terrorism-related elevated exposures, or for 
evaluating chronic environmental or other non-occupational exposures.
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Figure 1. 
Sequential sample preparation procedure for 241Am determination
* Samples containing U concentrations greater than 10 µg/L, add steps 5 – 6.
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Figure 2. 
Plot for 241Am LOD determination (60 runs per point).
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Xiao et al. Page 11
Table 1
Instrumental conditions and data acquisition settings for SF-ICP-MS measurements
RF Power (KW) 1.2 – 1.3
Cooling Gas flow (L/min) 16
Auxiliary Gas flow (L/min) 0.9
Sample Gas flow (L/min) 0.7 – 0.8
Lenses (V) Optimized as needed
Sample Take up time (min) 2.1
Wash (min) 3
Pump Speed During Wash (rpm) 1
LR Runs/Passes 3* 60
Detection Mode Triple
Measurement Units CPS
Scan Type ESCAN
Scan Optimization Speed
Number of Pre-Scans 5
Integration Type Average
Res. Switch Delay (s) 2
Resolution 300
Mass Window (%) 15
Setting Time (s) 0.001
Sample Time (s) 0.001
Samples Per Peak 200
Search Window (%) 20
Integration Window (%) 15
Measured Isotopes 241Am, 243Am
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Table 3
Comparison of CDC 241Am results with NIST target values for NRIP12 60 days samples*
Sample ID Massic Activity
(NIST Target Value)
Massic Activity
(CDC Observed Results)
Relative Expanded
Uncertainty (k=2)
Bias
(Bq/g spike) (Bq/g spike) (%) (%)
207 1.784 1.74 11.5 −2.52
212 1.784 1.74 11.2 −2.41
220 1.784 1.76 12.8 −1.57
224 1.784 1.74 12.5 −2.52
227 1.784 1.76 12.1 −1.63
214 1.784 1.74 12.3 −2.47
216 1.784 1.71 12.1 −4.09
228 1.784 1.75 12.2 −2.02
231 1.784 1.77 11.5 −0.95
232 1.784 1.77 11.2 −0.73
208 1.784 1.74 13.1 −2.75
211 1.784 1.74 13.0 −2.58
219 1.784 1.68 13.8 −5.61
223 1.784 1.76 11.7 −1.57
226 1.784 1.77 11.8 −1.01
*All samples were diluted 1:2 before DGA (Eichrom’s extraction chromatographic materials in which the extractant system is N,N,N’,N’-tetra-n-
octyldiglycolamide resin) separation
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Table 4
Comparison of CDC 241Am results with NIST target values for NRIP12 8 hours samples*
Sample ID Massic Activity
(NIST Target Values)
Massic Activity
(CDC Observed Results)
Relative Expanded
Uncertainty (k=2)
Bias
(Bq/sample) (Bq/sample) (%) (%)
215 0.146 0.14 11.0 −1.93
218 0.292 0.29 10.9 −0.62
222 0.149 0.15 11.1 −1.47
230 0.297 0.29 11.1 −1.99
234** 0.372 0.42 11.2 12.7
*Samples 218 and 230 were diluted 1:2 and sample 234 was diluted 1:4 before DGA (Eichrom’s extraction chromatographic materials in which the 
extractant system is N,N,N’,N’-tetra-n-octyldiglycolamide resin) separation
**Analyses for other radionuclides also produced unusually high results for this sample.
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